A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Clinical trial NCT06990399 · RECRUITING
Trial details
- NCT number
- NCT06990399
- Sponsor
- Kodiak Sciences Inc
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2027-04-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.